Delivery Order SPE2DB24D2101-SPE2DB25FKKSL

Award Date 5/20/25
Potential Completion Date 6/11/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $55,204.20 and a completion date of September 11, 2024. This contract is not associated with a set-aside program. Amerisourcebergen holds several Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $46,003.80 to Amerisourcebergen Drug Corp, the prime contractor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. The contract has a completion date of March 5, 2024 and was awarded on February 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp to provide...
This federal contract award is for the delivery of DARZALEX FASPRO, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The $34,267.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $70,709.40 and was awarded on April 16, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This is a $152,488.44 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML medical products, with a period of performance through June 3, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML. The $11,960.42 contract has a period of performance through May 28, 2025 and is not set aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which enables the company to provide a wide range of...
The Defense Logistics Agency (DLA) awarded a $33,122.52 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,563,692,912 units of DARZALEX FASPRO 1,800mg-30,000 15ml pharmaceuticals. The contract has a completion date of March 11, 2024 and was awarded on February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $198,735.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp. This contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $59,802.10, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 21, 2025. The award was made on April 30, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKKSL
    Delivery Order

The federal contract award is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $17,940.63 firm fixed-price delivery order contract has a completion date of June 11, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 20, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. The contract is not set aside and represents open competition.

Generated 8/24/25, 12:59 AM